Leeward Investments LLC MA lessened its position in Genpact Limited (NYSE:G – Free Report) by 13.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 239,082 shares of the business services provider’s stock after selling 37,717 shares during the period. Leeward Investments LLC MA owned about 0.14% of Genpact worth $10,522,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Cornerstone Planning Group LLC acquired a new stake in shares of Genpact in the 1st quarter valued at $27,000. Richardson Financial Services Inc. acquired a new position in Genpact during the 1st quarter worth about $35,000. SVB Wealth LLC acquired a new position in Genpact during the 1st quarter worth about $41,000. Steph & Co. acquired a new position in Genpact during the 2nd quarter worth about $37,000. Finally, Kestra Investment Management LLC acquired a new position in Genpact during the 1st quarter worth about $56,000. Institutional investors and hedge funds own 96.03% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on G. Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a research report on Saturday. Citigroup upgraded shares of Genpact to a “hold” rating in a research report on Thursday. Needham & Company LLC upped their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Mizuho upped their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 1st. Finally, Wall Street Zen downgraded shares of Genpact from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $51.13.
Insider Buying and Selling
In other news, CEO Balkrishan Kalra sold 55,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at $12,801,866.56. This trade represents a 15.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the transaction, the senior vice president directly owned 134,880 shares of the company’s stock, valued at $5,743,190.40. This represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by corporate insiders.
Genpact Price Performance
NYSE G opened at $39.48 on Friday. The business has a 50 day simple moving average of $42.29 and a 200 day simple moving average of $43.94. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. The stock has a market cap of $6.88 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.36 and a beta of 0.89.
Genpact (NYSE:G – Get Free Report) last posted its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period in the prior year, the business earned $0.79 EPS. Genpact’s revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact’s dividend payout ratio is presently 22.59%.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Best Stocks Under $10.00
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
